After the new automated factory began operations in 2019, BONA has continued to grow at an increasingly fast pace. In the last few years, the company has not only upgraded its production lines, but also improved its quality management structure. Moreover, it has heavily invested in R&D to make BONA products a perfect fit for any customer.

With the introduction of spray performance analytical devices, for example, our engineers can now help customize products in accordance with specific customer requirements and design spray systems for generic drugs as close to brand name drugs as possible. BONA can also support in-vitro bioequivalence evaluations and reports, including all tests listed below, to help develop new products at a faster rate:

• Delivered dose uniformity.
• Droplet size distribution (DSD) by laser diffraction.
• Spray Pattern & Plume Geometry analysis.
• Priming and repriming.

Please contact us for more information and solutions for generic or brand name products. We will try best to help reduce your development budget.